David Shapiro, CMO and EVP - Development at INTERCEPT PHARMACEUTICALS INC (ICPT), sold 1,118 shares at $119.00 ($133K) on 2017-08-01, disclosed to the SEC on 2017-08-02.
Seasonal sale ($133k) by CMO and EVP - Development — this insider has traded ICPT in August in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| ICPT | SELL | 2019-04-03 | $129K | — | Filing → |
| ICPT | SELL | 2019-03-01 | $206K | — | Filing → |
| ICPT | SELL | 2019-02-20 | $223K | — | Filing → |